Nano-X Imaging (NNOX) announced a strategic commercial agreement with Howard Technology Solutions. The agreement will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT. Under the terms of the agreement, Howard Technology Solutions will market and deploy 300 Nanox.ARC systems over a three-year period, 60 for the first year, and introduce the system to healthcare facilities and public sector customers across its national network.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging Posts Wider Q4 Loss but Accelerates U.S. Rollout and CFO Transition
- Options Volatility and Implied Earnings Moves Today, April 20, 2026
- Nano-X Imaging announces clinical collaboration with Meir Medical Center
- Nano-X Imaging subsidiary signs distribution pact with Digital X-Ray Imaging
- Is NNOX a Buy, Before Earnings?
